Share

March 28, 2017; 88 (13) Clinical/Scientific NotesOpen Access

BRAF/MEK double blockade in refractory anaplastic pleomorphic xanthoastrocytoma

Denis Migliorini, Diego Aguiar, Maria-Isabel Vargas, Alexander Lobrinus, Pierre-Yves Dietrich
First published February 24, 2017, DOI: https://doi.org/10.1212/WNL.0000000000003767
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1220

Share

Article Information

vol. 88 no. 13 1291-1293
DOI: 
https://doi.org/10.1212/WNL.0000000000003767
PubMed: 
28235815
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received August 26, 2016
  • Accepted in final form December 29, 2016
  • First Published February 24, 2017.

Article Versions

Copyright & Usage: 
© 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Denis Migliorini, MD,
    2. Diego Aguiar, MD,
    3. Maria-Isabel Vargas, MD,
    4. Alexander Lobrinus, MD and
    5. Pierre-Yves Dietrich, MD
  1. Denis Migliorini, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Diego Aguiar, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Maria-Isabel Vargas, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Alexander Lobrinus, MD and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Pierre-Yves Dietrich, MD
    6. Scientific Advisory Boards:

    1. Advisory board for BMS, Novartis, Amgen, Merck, Roche

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From Geneva University Hospital, Switzerland.
  1. Correspondence to Dr. Migliorini: denis.migliorini{at}hcuge.ch
View Full Text

Article usage

Article usage: February 2017 to April 2022

AbstractFullPdfSource
Feb 2017353019Highwire
Mar 201792330112Highwire
Apr 20174164076Highwire
Apr 2017122627pmc
May 2017801843Highwire
May 2017154553pmc
Jun 20171081132Highwire
Jun 201792832pmc
Jul 2017851243Highwire
Jul 201781919pmc
Aug 201716626Highwire
Aug 201741515pmc
Sep 201713426Highwire
Sep 201731820pmc
Oct 201717731Highwire
Oct 201792728pmc
Nov 201725423Highwire
Nov 201722827pmc
Dec 201721725Highwire
Jan 201852027Highwire
Feb 201891723Highwire
Mar 201812114Highwire
Apr 201821831Highwire
Apr 201862623pmc
May 20180816Highwire
Jun 201801512Highwire
Jun 201852325pmc
Jul 201842520Highwire
Aug 20183204Highwire
Aug 201811618pmc
Sep 20183219Highwire
Oct 201812315Highwire
Nov 20182512Highwire
Dec 20181165Highwire
Jan 20194258Highwire
Feb 20191495Highwire
Mar 201961418Highwire
Apr 201911537Highwire
May 201941235Highwire
Jun 2019102129Highwire
Jul 201913767Highwire
Aug 201907987Highwire
Sep 201937774Highwire
Oct 201956647Highwire
Nov 2019146512Highwire
Dec 201912563Highwire
Jan 20202128Highwire
Feb 20202133Highwire
Mar 20200154Highwire
Apr 20202113Highwire
May 2020297Highwire
Jun 20201117Highwire
Jul 20203128Highwire
Aug 2020273Highwire
Sep 20200218Highwire
Oct 20202198Highwire
Nov 20203129Highwire
Dec 202051312Highwire
Jan 20211127Highwire
Feb 2021241Highwire
Mar 20210103Highwire
Apr 20212158Highwire
May 202131710Highwire
Jun 2021296Highwire
Jul 2021388Highwire
Aug 20211168Highwire
Sep 20211176Highwire
Oct 202151123Highwire
Nov 202151215Highwire
Dec 202111910Highwire
Jan 20228227Highwire
Feb 20224261Highwire
Mar 20222167Highwire
Apr 20221177Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me